02:29 PM EDT, 08/23/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) informed certain hospitals that they will have to pay full price for two drugs the company sold under the drug-savings program and can then apply for rebates, the Wall Street Journal reported Friday.

The switch, which would take effect on Oct. 15, would mark a drastic change from the past pharmaceutical industry practice of providing the discount up front, according to the report, citing a letter that it viewed Johnson & Johnson ( JNJ ) sent to the hospitals.

Johnson & Johnson ( JNJ ) did not immediately reply to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 162.89, Change: +0.54, Percent Change: +0.33